Editorial: Personalized medicine for neuromuscular disorders.

Bartoli, Marc; Bailey, Rachel M; Meyer, Kathrin; Barthélémy, Florian

Bartoli, Marc; Bailey, Rachel M; Meyer, Kathrin; Barthélémy, Florian.

Afiliación

Bartoli M; Institut national de la santé et de la recherche médicale, Marseille Medical Genetics, U1251, Aix Marseille University, Marseille, France.
Bailey RM; Division of Child Neurology, Department of Pediatrics, University of Texas Southwestern, Dallas, TX, United States.
Meyer K; Center for Alzheimer's and Neurodegenerative Diseases, University of Texas Southwestern, Dallas, TX, United States.
Barthélémy F; Center for Gene Therapy, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States.

Front Cell Dev Biol ; 11: 1329048, 2023.

Article en En | MEDLINE | ID: mdl-38033860

Palabras clave

disease modeling; drug repurposing; gene editing; gene transfer; motor neuron; muscle; neuromuscular disease (NMD); therapy screening

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google